PATENT CLAIM ANALYSIS

Application Number: 16029228
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "211000"]

Abstract:
The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Claim (Index 1):
A compound of formula I, wherein R 1  is selected from the group consisting of\n i) aryl, \n ii) aryl, substituted by 1-3 substituents individually selected from cyano, C 1-6 -alkyl, halogen-C 1-6 -alkyl and halogen \n iii) heteroaryl, \n iv) heteroaryl, substituted by 1-3 substituents individually selected from cyano, C 1-6 -alkyl, halogen-C 1-6 -alkyl and halogen, and \n R 2  together with R 4  is selected from the group consisting of\n i) (CH 2 ), wherein x=3 or 4; substituted by 1 or 2 halogen-C 1-6 -alkyl, and \n ii) (CH 2 )(CY 2 ) z \u2014(CH 2 ), wherein each individual Y\u2550H or F and z=1 or 2, \n R 3  is selected from the group consisting of\n i) C 1-6 -alkyl, and \n ii) halogen-C 1-6 -alkyl; \n or pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15314718', '15105725', '15502044', '14400448', '13467085']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8389594547881596
- 35 USC 102 Novelty (BERT): 0.6036095455750162
- Combined Prediction Score: 0.8154244638668453
- Mean Citation Score: 422.914858
- Max Citation Score: 521.9717
- Similarity Product: 509.6678930854738

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test